EM-800 [182167-03-9]

MedChem Express

EM-800 [182167-03-9]

9

182167-03-9

Research Use Only

C39H47NO6

625.79

EM-800, an orally active anti-estrogen, serves as an antagonist to the transcriptional functions of estrogen receptors alpha (ERalpha) and beta (ERbeta). EM-800 possesses anticancer activity, capable of inhibiting the growth of breast cancer induced by 7,12-Dimethylbenz[a]anthracene (DMBA) (HY-W011845). Furthermore, in ovariectomized animals, EM-800 effectively slows down bone loss. Additionally, EM-800 shows potential in the research of breast and endometrial cancers, while exerting beneficial effects on bone and lipid metabolism[1][2].

CC(C)(C(OC1=CC2=C(C(C)=C([C@@H](O2)C3=CC=C(C=C3)OCCN4CCCCC4)C5=CC=C(C=C5)OC(C(C)(C)C)=O)C=C1)=O)C

12352200